Central regions | Finance, business | Technology & innovation

Russians develop advanced multiple myeloma drug candidate

16 Feb '18
Hemopharm, a Russian biotech company, is developing a drug candidate that might help multiple myeloma patients.

Multiple myeloma is a cancer of plasma cells. Initially, often no symptoms are noticed; but when advanced, bone pain, bleeding, frequent infections, and anemia may occur. Complications may include amyloidosis. Believed to be incurable, the disease stays with the patient for as long as he lives, and all physicians can do is increase his life expectancy and improve the quality of life. Drugs currently available in the market are known for high toxicity and low efficacy, which necessitates the development of low-toxicity target drugs to boost the patients resistance.

The new Hemopharm solution is expected to evolve to be such a drug. No direct competition has been reported so far in the global pharmaceutical market. The drug candidate is a humanized antibody with purportedly outstanding anti-tumor activity and low toxicity with proven in vivo efficacy.

Last fall Primer Capital, a Russian VC fund that invests primarily in pharmaceutical and biotech projects, supported an early development stage financially. Primer Capital Executive Director Elizaveta Rozhdestvenskaya then said in an interview that the fund expected preclinical trials to provide ample evidence to the high efficacy of the drug and promised to readily consider participating in the projects next funding round to back the clinical trial stage.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
Find Related Content


Tags: investment (548) / Primer Capital (5) / multiple myeloma (0) / Hemopharm (0) /

Latest News: Central regions
14 Mar '18 | Finance, business | Retail, FMCG
13 Mar '18 | Finance, business | Technology & innovation
12 Mar '18 | Finance, business | Technology & innovation
7 Mar '18 | Technology & innovation
28 Feb '18 | Technology & innovation | Finance, business

Feature stories

21 Nov '17
Russian scientists have come up with what they say is...
7 Sep '17
26 Jul '17
Scientists at Tomsk Polytechnic (TPU) in Siberia have...
Search (News archive - 21220)
Independent Software Developers Forum
Marchmont News

Latest News

19 Mar '18
New catalysts have been developed which are said to...
16 Mar '18
Super-hard and durable glass ceramics has been...
14 Mar '18
AURA Devices, a U.S.-registered Russian start-up, is...

Most read stories from last week

19 Mar '18
New catalysts have been developed which are said to...